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Introduction
he 6th Annual Connected Health Symposium, hosted by the 
Center for Connected Health, Partners HealthCare, is occur-
ring in mid-October 2009. In preparation for this meeting, 
the Center’s director, Joseph Kvedar, M.D., assembled a 
small group of individuals, each of whom will be featured speakers 
in Boston to discuss healthcare in these extraordinary times. As 
with all of the roundtables that we bring you, this one is particu-
larly poignant as healthcare reform is front page news and it is a 
key element and perhaps the largest initiative of President Obama’s 
first year in office. The assembled speakers are clear thought leaders 
from business and academia, and they have provided foresight in 
their discussion of the transformative change that must occur from 
supply chains: catalysts such as payment reform, new paradigms 
such as retail outlets, and a focus on wellness and prevention rather 
than on acute and reactive medicine. Disruptive innovations, which 
may not be revolutionary, are key change agents on both a micro 
and a macro scale. The outline of this roundtable was to perhaps lay 
a foundation for discussion both clinically and financially as reform 
is under way. It is clear that the assembled group is passionate 
about change and believes it must be done in a way that benefits 
the delivery of healthcare.
—Charles R. Doarn, M.B.A., Editor-in-Chief
JOSEPH C. KVEDAR: Our roundtable today is focused on the 
Connected Health Symposium entitled “Up from Crisis: Overhauling 
Healthcare Information, Payment, and Delivery in Extraordinary 
Times,” which will be held on October 21 and 22 in Boston. We’re 
very excited to have four Symposium speakers with us today who 
bring a great deal of knowledge and a diversity of viewpoints about 
the role of technology in healthcare delivery.
Many industries have been reshaped by technology and the 
Internet, among them the airline, financial services, and travel indus-
tries, where old paradigms for conducting business have been broken. 
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Whole industry segments have been disintermediated. At this time, 
however, healthcare hasn’t gotten there yet. I’d like us to use our 
experience and talk about some of our work, to peer into the crystal 
ball and suggest who the winners and losers may be when healthcare 
is transformed by technology, how that will happen, and what the 
catalyst for it might be.
LAURIE M. ORLOV: Although there is now an opportunity for 
transformative change in healthcare, it is enabled by all of the forces 
in today’s marketplace. I don’t necessarily believe that a change is 
guaranteed. Healthcare delivery is really not quite like other supply 
chains. In healthcare, a dollar in cost savings is a dollar of income 
lost in the supply chain. So one of my questions would therefore be 
to ask what motivates participants in a supply system to voluntarily 
cut their own incomes. And secondly, I would point out that some 
studies tell us that with electronic access to physicians, one in five 
visits to physicians could potentially be eliminated. In that context, I 
would note that one of the things automated by other supply chains 
was to tier the level of access so that the least costly access was the 
one utilized first. That is why, today, one is so often directed to the 
Internet before telephoning a human agent at a call center; and then 
a consumer always talks to a front-line call center agent before being 
redirected to an expert on the back end. That doesn’t seem to be work-
ing in quite the same way in the healthcare industry, and I’m not sure 
the real question is whether new technologies, rather than changes 
in workflow, would motivate participants in the healthcare delivery 
chain to model themselves after those in other supply chains.
JOSEPH C. KVEDAR: That’s fascinating. Tracey, can you comment 
on that?
TRACEY MOORHEAD: I’m strongly in agreement. There is enor-
mous opportunity for using electronic technologies in healthcare 
delivery, and for creating better incentives for streamlining the deliv-
ery of care. I agree that many technologies do have the potential to be 
disruptive to the existing system, but until we better align the goals 
of an economical and effective healthcare delivery system, and elimi-
nate the fragmentation in the provision of care and reimbursement 
for it, we won’t be able to capitalize on those opportunities.
JOSEPH C. KVEDAR: Jason, do you think that the noise coming out 
of Washington about payment reform is sufficient to be a catalyst for 
this kind of change?
JASON HWANG: I think it ties into the question of whether tech-
nologies themselves are sufficient to drive change in the healthcare 
industry. I think that in general, the approach that we’ve taken his-
torically, and what is now happening in Washington, is the wrong 
approach—simply expecting that somehow, the leaders of the health-
care industry should become more efficient and better at what they’re 
trying to do. And yet, as we’ve seen time and time again in other 
industries, including the financial services and airline industries, 
there is no way to force companies like Morgan Stanley or United 
Airlines to somehow become more cost effective. Their business mod-
els simply weren’t suited to make money at a lower rate, as a firm like 
Charles Schwab could, for example, in the financial services industry. 
It was not in their interest to pursue that type of course, even though 
the technologies for doing so were available to them. In fact, given 
their resources, they probably had access to those technologies first, 
before Schwab ever did.
And likewise, in healthcare, cutting reimbursement rates, for 
example, is the general approach taken when it comes to trying to 
reduce the cost of care. And yet that approach is predicated on the 
ability of hospitals and physicians to somehow, themselves, become 
more efficient at what they’ve always done. That can work to a cer-
tain degree, but again, the disruptive approach, in which a lower-cost 
player can create a sustainable healthcare system that can still make 
money, is what is really needed. And so a new business model, which 
utilizes technologies in a disruptive fashion rather than expecting 
them to change the way in which existing stakeholders do business, 
would really seem to be the right approach.
PETER A. UBEL: I completely agree, and the Obama Administration 
is investing a lot of money in the electronic medical record in the 
hope that it will help control healthcare costs. But its success depends 
on how people use the electronic medical record. It might make doc-
tors more efficient at billing for what they do and therefore increase 
costs. So the technology is only a part of the package; you have to 
look at how people will behave with that technology.
JOSEPH C. KVEDAR: Trying to summarize a bit the theme on which 
we all seem to agree, technology is an enabler. What is required is 
perhaps some sort of catalyst for a new business model in healthcare 
delivery. We still haven’t heard what that might be, and I think it’s 
still something of a mystery. I don’t think that the ideas for payment 
reform coming out of Washington are enough to be transformative, 
although I do think they represent a step in the right direction.
Before we move away from this particular topic, I’d like to ask whether 
anyone would like to speculate on what might be the catalyst for a new 
business model in healthcare delivery. As one possible instance, retail 
clinics are said to be a disruptive innovation. Is that the kind of thing 
we’re going to see, the straw that breaks the camel’s back? 
TRACEY MOORHEAD: I do believe that retail clinics have a role to 
play in a new paradigm of healthcare. I don’t believe that they’re the 
straw that will break the camel’s back. But, particularly as we seek to 
focus our healthcare delivery system more on prevention and well-
ness, I do think that we should rely on retail clinics for the services 
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that they can help to provide to certain segments of the population 
that need those services.
LAURIE M. ORLOV: I’d like to also offer the pharmacy, in addition 
to the retail clinic, as an organization through which nearly every-
body passes. And I wonder whether pharmacies, perhaps instead of 
the primary care physician, might become more of a hub of informa-
tion-sharing in the healthcare delivery chain.
TRACEY MOORHEAD: I think Laurie is right. This discussion is 
moving toward what we were referring to earlier as a new business 
model that utilizes technology as an enabler for better connecting 
the various points at which the individual citizen—whether healthy, 
at risk for illness, ill, or chronically ill—can receive care, and how to 
ensure that that care is coordinated across all of those points. But as 
another speaker was saying, technology is not going to be of any 
assistance in helping to redesign the model if it isn’t appropriately 
utilized by the various providers.
JOSEPH C. KVEDAR: I’d like to ask Peter a question about behav-
ioral economics. A healthcare system clearly involves multiple stake-
holders, and we have talked about some of them, whether they are 
health plans, payers, providers, patients, families, social networks, 
other caregivers, pharmaceutical manufacturers, or pharmacies. Is 
there a component of behavioral economics in which both quality 
of life and cost-effectiveness can be enhanced by behavioral adjust-
ments shared by some or all participants in the healthcare value 
chain, and not only the patient? Does the answer really lie in moving 
the patient to healthy behavior, after which everything else will fall 
into place?
PETER A. UBEL: I think it’s essential to address the issue of how 
behavioral economics affects healthcare reform, wherever these two 
factors end up meeting. But there is no way in which we can expect 
patients alone to bear the burden of reform or to make all of the 
changes necessary to reform the system. I think that there are two 
points in behavioral economics that will help us to understand the 
ways in which we can succeed or fail in reforming healthcare deliv-
ery. The first is whether we can get people thinking about gains or 
losses. And the second is whether we can get them to think about 
their present situation or their future. Right now we have hope for 
healthcare reform because people are afraid that at some time in the 
future they may lose their healthcare coverage, and because many 
people have already lost their healthcare coverage.
The problem we face is that if it’s going to succeed, healthcare 
reform is going to cause a great amount of change from what we 
now have. If we’re going to control healthcare costs, we have to 
make major changes in the system, and in most people that triggers 
a sense of loss, and of worry that they’re going to lose access to their 
physician or to the kinds of medications or other treatments or tests 
that they’re used to receiving. That is a very strong emotional force 
and will make people oppose reforms.
LAURIE M. ORLOV: One of the things that we haven’t talked about 
is the extent to which, as deductibles increase and more consumers 
possibly lose their healthcare insurance, they go outside the system 
altogether and focus on self-care, with devices they might buy to 
check their own vital measures at home. Or they may focus on alter-
native medicine, which is a private pay-for-care industry. So from a 
consumer standpoint, it has to do with how healthcare services can 
benefit the individual consumer. And from the provider standpoint, 
the question is: “How can I remain cost-effective in delivering care?” 
The degree to which these two things intersect is what will yield a 
behavioral economic model for change in healthcare delivery.
JOSEPH C. KVEDAR: I would argue that none of the groups that I 
mentioned—whether the patient, family, friend, provider, or payer—
has quite the right incentives at present. So there are incentive oppor-
tunities all the way along. Just to begin with, half of our healthcare 
costs can be attributed to unhealthy behaviors, and so there are 
certainly things we can do as individuals, consumers, and patients to 
improve our own health. Physicians and other care providers have 
the incentive to get through the day with as little disruption as pos-
sible, even if it may mean doing more costly things. So there is plenty 
of room for incentives and penalties.
To move to another theme, I wanted to ask Tracey, on the basis 
of her experience at DMAA: The Care Continuum Alliance where she 
encounters a kaleidoscope of viewpoints about healthcare delivery, 
whether she might point to one or two things that need to be done 
now to ease the current crisis and move toward an America in which 
patients are empowered to better manage their own care, providers 
have the right tools for permitting this, and elders have the ability to 
remain independent in their own homes for as long as possible.
TRACEY MOORHEAD: I think there are a couple of things that can be 
done in that direction. One of the most important is to ensure that every-
one has access to coverage. I don’t think there is any single answer for 
how to provide that access, because of the multitude of current reasons 
for why someone could lack coverage. But I do think that providing cov-
erage for all people needs to be a primary goal of healthcare reform.
Secondly, I think that we need to shift the healthcare system gener-
ally from one that is focused on acute and reactive care, which was the 
basis on which our healthcare system evolved, to one that gives much 
greater priority to and focuses much more on wellness and prevention. 
That shift needs to permeate every aspect of our society, from chang-
ing the way in which school lunches are delivered and children are 
educated about healthy activities and healthy behaviors, to the training 
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of physicians in medical school about the importance of encouraging 
healthy behaviors in patient populations. It should even be inherent 
in the management of physicians’ clinical practices so that they focus 
more on treating acute illnesses and delegate more responsibility for 
management of healthy persons or patients at risk for illness to other 
providers, such as nurse practitioners or diabetes educators.
I think that accomplishing such a shift from acute and reactive 
to preventive and wellness-focused care would allow us to free up 
resources that would provide greater access by the chronically ill and 
other patient populations to the types of services that they require. 
Those are two of the overarching themes that we’re seeing emerge 
through the healthcare debate. And underlying each of these goals is 
the need for the various components required to achieve them, such 
as health information technologies.
JASON HWANG: Something I would like to address is the theme 
of decentralizing healthcare. The bottom line is moving the tools and 
the information required for the delivery of care closer to the patient, 
and even putting them directly in the hands of the patient. Coming 
up with the means to that end result is really one of the core mes-
sages of our work.
When you use disruptive technology appropriately, you’re enabling 
the new business models, like the ones we discussed earlier, in a 
way that permits new venues of care to develop and new people 
to become care providers. You’re no longer centralizing care in the 
hospital, and ultimately and ideally, the patient can take over his or 
her own care.
PETER A. UBEL: The most familiar example of patients taking 
charge of their own care is that of diabetes care and what the glu-
cometer has done in that area. Often when I’m talking with physi-
cian audiences about disruption, I sense great fear about sacrificing 
the patient’s safety and a feeling that we’re doing them a disservice 
when we move care out of the professional’s hands. Yet when one 
goes back through the history of medicine, one can start to see that 
time and time again, and often unintentionally, we’ve shifted some 
responsibility for care to patients. That is, provided that the care has 
reached a high level of precision and delivery of the care has become 
rules-based so that it can be guided by a simple algorithm and you 
no longer need medical expertise to deliver it.
Diabetes care, at least for simple sugar management, has reached 
that point, with a set of rules that patients can follow at home to 
administer their own insulin shots.
JOSEPH C. KVEDAR: Another example of this is our hypertension 
self-management program at the Center for Connected Health, where 
we did a randomized controlled trial with employees at the data 
storage company EMC, Inc. In this study, we used a blood-pressure 
cuff device to move patients’ information collected at home onto 
the Internet. We then displayed back to the patients their readings, 
the context of the readings, and an automated coaching algorithm 
to send them action-oriented messaging designed to change their 
behavior, when needed. In 6 months of testing the interactive system, 
we found a high degree of adherence, with less than a 1% dropout 
rate. At the end of the 6-month period, the participants were still 
logging on once a week, as we asked them to do, and were upload-
ing their blood pressures readings three times a week, as we had also 
requested. And their blood pressures were significantly lower than 
that of the control group. So that’s an example. We’re now extending 
that in another trial that offers patients algorithms for changing their 
own medications on the basis of their blood pressure management.
JASON HWANG: I’d like to connect that program to our earlier 
discussion illustrating that an acute illness model that is poorly suited 
to serve as the basis for dealing with chronic diseases and behavior 
management. I think that decentralizing care and shifting it to the 
home is clearly the path to reaching the goal of changing the existing 
healthcare system. We do our patients a disservice when we tell them 
that the best way to manage their diabetes is to see their physicians 
for 15 minutes at a time every two or three months, when they have 
to deal with their disease 24 hours a day. Decentralizing care and 
putting more information and control of disease management in the 
hands of the patient is really the only way to effectively reduce what 
amounts to 75% of our national healthcare cost.
JOSEPH C. KVEDAR: The term “continuous care” as opposed to “epi-
sodic care” has been used to describe that model. It’s a very powerful 
model. I do think that the way in which to finance it is still a chal-
lenge. Some of the things that we’ve found encouraging—such as the 
warning that Medicare will no longer pay for 30-day readmissions—are 
very much a harbinger for a new payment model. And so is a bundled-
payment type of scenario. We’ve also heard talk of shared-savings 
scenarios, which are also interesting. We have to see what unfolds, and 
just how many teeth the government will put into payment reform to 
determine whether any of this can really be meaningful.
The other point I’d like to make is that, in our experience, if you 
give healthcare providers the problem of setting up the medical home, 
or asking them to solve the issue of more continuous care, providers 
come up with a scenario in which they hire more staff. Their solution 
isn’t to do things very differently from the way in which they’re now 
doing them. It’s incumbent upon those of us who have experience 
with different models of care, and know that they’re successful, to 
become evangelists for these models.
LAURIE M. ORLOV: I would add that there seems to exist almost an 
inversely proportional relationship here between the degree of decen-
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tralization of care and the degree of centralization and potential for 
dissemination of information. Thus, for example, the more you have 
standardized and centralized information about a specific patient that 
can be shared among multiple healthcare providers, the more you can 
effectively decentralize care. Otherwise you’re really throwing the 
care out into the arena without necessarily managing it.
PETER A. UBEL: I’m a primary care physician and like much of 
what I’m hearing. I try very hard to have a partnership with my 
patients, who to a great extent have to manage their own chronic 
illnesses. But I don’t think we can expect a great deal of cost savings, 
even if the model that we’ve just been discussing were to get enacted 
and succeed. I don’t think that 75% of care costs are consumed by 
chronic disease care.
I don’t know how much of current care costs they would save, if 
any. I’m not sure that really tight blood sugar control saves money. 
And so I think that while we want to encourage patients to get 
involved in their own care, and that knowledge is a very important 
part of their doing that, we have to look elsewhere if we’re really 
seeking to save a lot of the cost of medical care.
JASON HWANG: As a primary care physician myself, I also think 
that we need to distinguish between cost cutting and more cost-effec-
tive care. Many studies have shown that prevention and behavioral 
interventions aren’t necessarily cost-saving, but that they are cost-
effective. And the emphasis on that point of their being an invest-
ment is one of the positive aspects of the Obama Administration’s 
current platform. I don’t expect that having nurses teach patients 
with diabetes how to eat and how to self-inject and how to tightly 
manage their glucose is going to reduce costs in the long run, but 
it is nevertheless cost-effective care, because it will ideally prevent 
greater downstream costs. So my goal is again not necessarily to trim 
costs such that they no longer climb exponentially, but rather to get 
in return the value increase for our investment.
JOSEPH C. KVEDAR: This is an important nexus in the debate about 
what is and isn’t cost-effective and cost-saving. Is anyone convinced 
that these new care models that we’re discussing, facilitated by tech-
nology and patient-centric care outside the traditional care settings, 
will result in cost savings? I’ll give anyone the chance to state that case 
before we talk about nuances of cost-effectiveness and so forth.
TRACEY MOORHEAD: I think it depends on the technology and 
resources required, and the patient population that is involved. The 
President essentially said, in a recent speech in Wisconsin, that bet-
ter management of a diabetic patient’s condition can save $3,000 
by avoiding an amputation as opposed to costing $500 for a nurse-
coach. I agree that you can save money by avoiding exacerbations 
or acute complications, and that adding more people and paying for 
coverage for more people and helping more chronically ill or at-risk 
patients to better manage their condition may very well result in 
greater expenditures across the board. However, it will yield better 
outcomes in terms of health. And that gets to the question of value 
propositioning and what we’re going to value most greatly. Are we 
going to value improved health status and quality of life, which 
I think is the shared goal of everyone looking toward healthcare 
reform? If so, I don’t think that we can expect to see dramatic cost 
savings, but I do think that we can expect better cost efficiencies and 
better-coordinated care for individuals.
JASON HWANG: I’d like to provide a classic out-of-industry 
example of cost versus value, because it’s one that people tend to 
grasp well. It has to do with the disruption in the computing industry 
brought on by the advent of personal computers in the era of more 
traditional mainframe and minicomputers. When the computing 
world was in the era of minicomputers, few people had access to 
computing power. One had to visit a corporate mainframe center to 
gain such access. And when the personal computer disrupted that, 
and a lot more people could afford and use computing technology, 
the world began to spend far more money on computing than it ever 
had in the era of the mainframe or minicomputer. Today, everyone is 
better off because of that.
So again, looking at value as opposed to simply looking at costs 
or expenditures seems to me to be the right approach. If the disrup-
tion brought to the computing industry by the personal computer had 
not happened, we would have been stuck in the era of mainframe 
computers and been telling ourselves that the way to control costs in 
mainframe computing was to not buy so many mainframe comput-
ers. But instead, we came up with a disruptive technology that was 
much more affordable and inclusive in being decentralized and giv-
ing many more people access to computing power and data sharing.
LAURIE M. ORLOV: In terms of the mainframe and the PC, I know 
that today we’re all addicted to computers and the Internet, but there 
have been studies showing that not one ounce of white-collar pro-
ductivity has been gained from all that innovation.
JOSEPH C. KVEDAR: I’d like to carry this thread a bit further. The 
United States already spends as much as 20% more per capita on 
healthcare than the next highest spending westernized country. We’re 
off the charts as compared to our neighbors. I hear some people say 
they don’t know whether this or that measure will cut costs, but it 
will add value and quality. Are we then saying that we could greatly 
increase quality, perhaps at the same costs we currently have? If so, 
we ought to remember that we already spend far more than the next 
closest country on the economic chart. How are we going to deal with 
that? I do think that the approaches we’re offering will cut unneces-
© MARY ANN LIEBERT, INC.  •  VOL. 15  NO. 7  •  SEPTEMBER 2009  TELEMEDICINE and e-HEALTH  639
OVERHAULING HEALTHCARE INFORMATION, PAYMENT, AND DELIVERY
sary costs, but as Peter was saying, there will probably be other costs 
that spring up with these approaches that we haven’t thought of. 
However, I also believe that the strategies we’re talking about will 
probably also provide additional value.
I’d like to hear your views on this conundrum. If we already spend 
far too much on healthcare, and can’t commit to cutting costs, are 
these approaches really going to raise the value of the returns by so 
much?
LAURIE M. ORLOV: An executive in a firm called Consult-a-Doctor, 
which provides telephone-based physician visits, gave me a relative 
cost ratio in which an in-person visit to a physician insured by Blue 
Cross can cost $150, an emergency room visit can cost $1,200, a pre-
scriptive diagnostic visit by telephone costs $30, and an e-mail-based 
visit would be free. In view of that, I don’t understand why interactive 
methods of providing medical care wouldn’t reduce costs.
PETER A. UBEL: Randomized trials of primary care have shown that 
increasing access to primary care increases the cost of care because it 
means that physicians start ordering more tests and other diagnostic 
procedures and make new findings that must then be addressed. The 
question here is again whether this improves value. We can still ask 
whether this constitutes making good use of tests and other proce-
dures, but that doesn’t necessarily translate into lower costs.
JOSEPH C. KVEDAR: I think we may be talking about different 
things. It could be true that traditional access to office-based primary 
care may not be the right way out of the conundrum of cost versus 
scope of care, but I liked the thinking in Laurie’s comment about 
nontraditional methods of access, such as e-mail or telephone, and 
I’d appreciate it if she could expand a bit on that.
LAURIE M. ORLOV: One of the concepts is that of the mini-clinic 
or walk-in clinic, for which the cost of a visit is half that of a pri-
mary care visit. It seems to me that the idea of using technology to 
triage someone to the lowest cost form of care that is appropriate, 
using relevant information and algorithmic or other intelligence, is 
more the goal for cutting costs than increasing access to primary care 
physicians in the traditional system.
Also very interesting is the AARP Healthy at Home 2008 study, 
which dealt with the use of technology in the home in caring for 
senior citizens and their views and the views of caregivers.
One of the points of that study was that 96% of the senior citi-
zens surveyed wanted to help their physician to monitor their health 
through the use of technology, if that was at all possible. Most were 
willing to pay for the necessary technology, as long as the price was 
under $50 a month. I realize surveys asking people about their will-
ingness to do such a thing is not the same as surveying people who 
have actually used such technologies. I realize these are two different 
things. One of the key points in the Veterans Administration’s 2008 
study looking at the efficacy of using multiple telehealth technologies 
such as videophones, digital cameras, telemonitoring, and monitoring 
of vital signs—and a point that I think we still haven’t seen outside of 
the VA’s vertically integrated healthcare system—was that coordina-
tion of care integrated well both with information technologies and 
with patient self-management.
JOSEPH C. KVEDAR: That’s a useful observation in terms of 
coordinating care and information technology for patient self-
management. 
LAURIE M. ORLOV: The perspective is really that of a workflow 
process.
TRACEY MOORHEAD: Speaking on behalf of DMAA, I’d like to 
thank Laurie for basically reiterating our primary strategic goals.
JOSEPH C. KVEDAR: Well, even though we may not have solved 
the cost problem, our discussion so far has at least given us some 
potential insights into it. As we move ahead, though, we still have the 
burden of thinking about whether the interactions we’ve discussed as 
nontraditional visits, an e-mail visit, or a trip to a mini-clinic carry 
a cost, even if the cost is to a different sector of the system, just 
as using a telemonitoring program to reduce readmission for heart 
failure adds cost. It’s not net cost positive, but it’s not neutral cost, 
either. It adds costs in the arena of more nurses needed to do the 
telemonitoring, costs for follow-up, and other costs. Those are the 
kinds of things about which we have to be thoughtful when stating 
numbers.
I want to ask Jason to speak further about disruptive technology 
in healthcare. The book he co-authored with Clayton Christensen, 
The Innovator’s Prescription: A Disruptive Solution for Health Care, 
published by McGraw-Hill, as well as other books that he has written, 
have really made disruptive technology something of a living-room 
term. Can a technology be disruptive to healthcare? I thought that 
what Laurie said about a dollar saved being a dollar of income lost 
was salient. How are we going to overcome that with a disruptive 
technology?
JASON HWANG: I think it’s important to first resolve some of the 
misinterpretations and misunderstandings about what disruptive 
innovation means. It’s a mistake to think that disruption is equiva-
lent to revolutionary. Often what we’ve called disruptive systems or 
technologies are simple business models or simple technologies that 
dramatically change the way in which healthcare is delivered. I think 
it’s also a mistake to believe that disruption necessarily leads to infe-
rior quality or safety. Part of that is our own doing, because when 
we use examples from outside the realm of healthcare, we’re often 
talking about a genuinely disruptive entrant. But in healthcare, we’re 
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clearly not willing to sacrifice patients’ health in order to somehow 
introduce a disruptive innovation.
For example, with the retail clinic model, which is quite illustrative 
of some of the basic principles involved in algorithmic or rules-based 
care, one is no longer dependent on the intuition and training of a 
physician. There is little room for error because the system is very 
process-oriented and outcomes are therefore predictable and safe, 
and in a growing number of instances, are in fact being guaranteed 
by the healthcare provider.
Frequently, then, when we talk about disruptive innovation and 
providers wave the red flag of safety and warn that we can’t allow it 
to be compromised, they’re really exhibiting the guild mentality that 
often arises when we’re trying to change the established system of 
professional care.
I want to make it clear that our goal is not to put doctors and 
hospitals out of business, but to free them so that they can truly 
take care of the patients that deserve their attention. The problem 
with today’s healthcare delivery system is that we pay providers to 
deal with problems that they don’t necessarily need to be dealing 
with, and that their time could be better spent elsewhere, and we 
ought to pay them to spend that time elsewhere. Our belief is that 
every professional should be able to practice to the limit of their skill 
and licensure, and not be relegated to dealing with issues that don’t 
fully utilize their expertise and training. So redefining workflows 
and bringing in the workforce that can deal with multiple levels of 
problems, rather than our continuing to pay for a centralized system 
of care—a one-size-fits-all system—is really an overarching goal of 
disruption in healthcare.
JOSEPH C. KVEDAR: Peter, how does it strike you, as a practicing 
primary care physician, that we should pay you only to do the things 
that you’re really most needed for, and should pay others to do the 
other things? Do you think that’s workable?
PETER A. UBEL: I don’t know whether that’s workable. I think 
that what is really driving today’s healthcare costs are how much we 
charge for what we do and how much we do. Those questions are as 
important as any of the other things that we’ve talked about today. 
I think that changing how payment is made and what is being paid 
for are the keys to controlling healthcare costs.
JOSEPH C. KVEDAR: We’ve talked a lot about disrupting tradi-
tional healthcare and moving the cost needle in healthcare. I’m going 
to shift gears a bit and talk about the consumer. Our experience at 
the Center for Connected Health has been that, for matters of health 
and wellness, we see a market for the device-based data uploads and 
other kinds of tools that we promulgate. Currently, though, as soon 
as someone gets a diagnosis of illness, we hear the hue and cry that 
“I want my health plan to pick it up; why would I want to pay for 
that?” How will we get these technologies embedded in the home 
and get consumers to pick up part of the costs for them? Earlier on, 
Laurie mentioned alternative medicine as an essentially cash-and-
carry market in healthcare. I’m going to ask Laurie to comment on 
whether it might not be conceivable and feasible for individuals to 
buy the necessary devices and monitor their own health.
LAURIE M. ORLOV: I think it’s interesting that consumers are willing 
to pay out of pocket for alternative therapy. That could be acupuncture, 
it could be home health remedies, and many other things. So I wonder 
whether the problem with the consumer recalcitrance that you men-
tioned isn’t in the presentation of the cost, in the context of the current 
insurance and healthcare system, rather than in the cost of the technol-
ogy itself. I recently heard about a study in which Philips Telehealth 
Solutions engaged patients in 60 days of home telehealth monitoring. 
The study participants were very happy to have the home telehealth 
monitoring devices in their homes and, in fact, felt that someone was 
actually paying attention to and caring about them by telephoning 
them and saying, ”Your blood pressure seems to have changed. Did 
you just have something different for dinner?”
At the end of the 60-day period, a number of the patients expressed 
willingness to keep their monitoring devices and monitor their own 
condition. They wanted to keep the data for themselves and not 
necessarily share it with their physicians, apparently for fear of being 
labeled as continuing to have a disease.
And I would also return to that point in the AARP study about 
96% of the patients wanting to help the physician monitor and man-
age their own health, as long as the price for the necessary technol-
ogy was below $50 a month. I think that if you put these points 
together, you see that the issue is really more in the presentation of 
the cost and its context. 
JOSEPH C. KVEDAR: It almost sounds as if you were describing our 
program of telemonitoring for heart failure at Partners HealthCare. 
We have quite a few instances in which elderly patients, who consti-
tute most of the population with heart failure, ask us to please leave 
the monitoring technology in their homes because they feel it’s a 
lifeline. They like the fact that a nurse is phoning them and remind-
ing them to take their vital signs and watch their diets, that someone 
is looking after them. So we agree about that.
The catch is knowing that, in our system, the cost of the technol-
ogy and the cost of the program itself is $200 or $300 a month. 
None of our patients have yet reached into their pockets to fund that 
sum. When they hear that price tag, they just can’t do it. Regrettably, 
that would seem to address the issue of the $50 cutoff that you 
mentioned. And we haven’t found a way to get heart failure tele-
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monitoring down to anywhere near $50 per month, although some 
of our other programs are less costly than that, and maybe they offer 
an opportunity for patient-based support.
TRACEY MOORHEAD: I think there are two points here. One goes 
back to the issue of aligning incentives and helping patients to under-
stand the benefits that they can get through better care coordination 
and utilization of various technologies. Over the longer term, I think 
there is a real opportunity among people who want to age in their 
homes, and whose family members or other caregivers don’t live 
nearby. Many patients are beginning to express interest in monitor-
ing technologies, whether visual technologies or other remote moni-
toring technologies, that can allow their relatives or other caregivers 
to keep better tabs on their health status, such as how often they take 
their medications and whether they’re eating well.
I’m hearing ever more frequently from DMAA members that there is 
growing awareness of the benefits of this, not only to patients and their 
caregivers, but also to healthcare professionals. I think that helping to 
implement the necessary technologies for these populations will help to 
educate an expanded population about the benefits of these technolo-
gies, and will make the costs involved in them more readily acceptable.
LAURIE M. ORLOV: We’re probably all familiar with personal emer-
gency response systems, such as Philips’ Lifeline system. I seem to 
remember that even though devices like that are marketed directly 
to elderly consumers, their cost is split fairly evenly between those 
consumers and their adult children. So that represents an example of a 
situation in which adult children recognize the value of these devices, 
and I think that can translate into the acceptance of such technologies 
by multiple segments of elderly people and their adult children.
Right now, something on the order of 50% of all Baby Boomers 
have at least one living parent, and right now, we’re in a time when 
large numbers of people are unable to sell their homes and move into 
assisted-living or independent-living communities. I think that makes 
the present an optimum time for discussing cost sharing in the use of 
new healthcare technologies.
JASON HWANG: That again fits in with the concept of decentral-
ization and shifting care outside of the centralized system, which to 
my mind is a much more cost-effective way of delivering care and 
improving access to it.
LAURIE M. ORLOV: The only thing I would add is that the cost 
of a personal computer in the home has been dropping almost on 
a regular basis, and that includes the cost of touchscreen personal 
computers, software that makes them easy to use, and a video camera 
to go on top of a personal computer. All of that can now be had for 
less than $500. That starts to make the personal computer look really 
appealing as a platform for information exchange between patients, 
their adult children, their caregivers, and healthcare cost payers.
JOSEPH C. KVEDAR: When I started my journey in telehealth in 
1994, I was involved in imaging and dermatology, and the camera 
that we used had less resolution than the camera in a modern cell 
phone, but cost $12,000. That is an example of progress in technol-
ogy and cost reduction. As we look into the future, I think that what 
we’re talking about will go in that direction.
We’ve had a very rich dialogue and I thank each of our speakers 
today for sharing their perspective and insight. We will continue to 
share ideas, learn from each other, and discuss the future of health-
care delivery at our upcoming Connected Health Symposium.
